Celadon Pharmaceuticals (LSE:CEL) Pretax Margin % : -4,594.87% (As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Celadon Pharmaceuticals Pretax Margin %?

Pre-Tax margin is calculated as Pre-Tax Income divided by its Revenue. Celadon Pharmaceuticals's Pre-Tax Income for the six months ended in Dec. 2023 was €-3.58 Mil. Celadon Pharmaceuticals's Revenue for the six months ended in Dec. 2023 was €0.08 Mil. Therefore, Celadon Pharmaceuticals's pretax margin for the quarter that ended in Dec. 2023 was -4,594.87%.

The historical rank and industry rank for Celadon Pharmaceuticals's Pretax Margin % or its related term are showing as below:

LSE:CEL' s Pretax Margin % Range Over the Past 10 Years
Min: -282200 Med: -74400 Max: -10036.78
Current: -10060.92

LSE:CEL's Pretax Margin % is ranked worse than
98.53% of 1020 companies
in the Drug Manufacturers industry
Industry Median: 4.33 vs LSE:CEL: -10060.92

Celadon Pharmaceuticals Pretax Margin % Historical Data

The historical data trend for Celadon Pharmaceuticals's Pretax Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Celadon Pharmaceuticals Pretax Margin % Chart

Celadon Pharmaceuticals Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Pretax Margin %

-282,200.00

-74,400.00

-10,036.78

Celadon Pharmaceuticals Semi-Annual Data
	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Pretax Margin %	Get a 7-Day Free Trial			-167,450.00	-120,607.69	-35,720.00	-57,433.33	-4,594.87

Competitive Comparison of Celadon Pharmaceuticals's Pretax Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Celadon Pharmaceuticals's Pretax Margin %, along with its competitors' market caps and Pretax Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Celadon Pharmaceuticals's Pretax Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Celadon Pharmaceuticals's Pretax Margin % distribution charts can be found below:

* The bar in red indicates where Celadon Pharmaceuticals's Pretax Margin % falls into.

Celadon Pharmaceuticals Pretax Margin % Calculation

Pretax margin - also known as pretax profit margin is the ratio of Pretax Income divided by net sales or Revenue, usually presented in percent.

Celadon Pharmaceuticals's Pretax Margin for the fiscal year that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pre-Tax Income (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-8.732	/	0.087
	=	-10,036.78 %

Celadon Pharmaceuticals's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as

Pretax Margin	=	Pre-Tax Income (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	-3.584	/	0.078
	=	-4,594.87 %

Celadon Pharmaceuticals (LSE:CEL) Pretax Margin % Explanation

The pretax margin, as know as pretax profit margin, is widely used to measure the operating efficiency of a company before deducting taxes.

The pretax margin is sometimes preferred over the net margin as tax expenditures can make profitability comparisons between companies misleading.

It is a useful tool to compare companies operating in the same sector and less effective when comparing companies from other sectors as each industry generally has different operating expenses and sales patterns.

The long term trend of the pretax margin is a good indicator of the competitiveness and health of the business.

Celadon Pharmaceuticals Pretax Margin % Related Terms

Thank you for viewing the detailed overview of Celadon Pharmaceuticals's Pretax Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Celadon Pharmaceuticals (LSE:CEL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Celadon Pharmaceuticals PLC (LSE:CEL) » Definitions » Pretax Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

32-33 Cowcross Street, London, GBR, EC1M 6DF

Website

https://www.celadonpharma.co.uk

Celadon Pharmaceuticals PLC focuses on growing indoor hydroponic high-quality cannabis initially for use within the chronic pain market. It has two reportable segments Celadon is a Build of grow facilities, growing medical grade cannabis and research in the GMP lab, and Harley Street (CPC) is a clinical study into the pain relief benefits of medicinal cannabis.

Celadon Pharmaceuticals (LSE:CEL) Headlines

No Headlines